Alnylam Pharmaceuticals, Inc. (ALNY)
320.00
-8.16
(-2.49%)
USD |
NASDAQ |
Feb 09, 16:00
321.00
+1.00
(+0.31%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap : 42.28B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 31.89B |
| Biogen, Inc. | 28.44B |
| Pfizer Inc. | 153.80B |
| Eli Lilly & Co. | 935.00B |
| Bristol Myers Squibb Co. | 123.71B |
Market Cap Related Metrics
| PE Ratio | 1330.56 |
| PS Ratio | 13.13 |
| Price to Book Value | 180.75 |
| Price to Free Cash Flow | 190.37 |
| Price | 320.00 |
| Earnings Yield | 0.08% |
| Operating PE Ratio | 159.20 |
| Normalized PE Ratio | 206.44 |